Inclusive Care in Alopecia: Beyond Diagnosis
Alopecia areata (AA) exhibits considerable heterogeneity in its clinical presentation. Are you aware how this affects diagnosis, treatment, and patient quality of life?
This multi-part series focuses on AA in specific populations, including skin of color patients and adolescents. It will include three articles, a downloadable infographic, an expert-led webinar, and patient and physician interviews.
Over the next year, this series will provide a range of learning opportunities:
- Understand diagnostic and severity assessment challenges in skin of color (SOC) patients, and review the best practices for diagnosing and managing AA in these patient populations
- Review the treatment landscape for AA and how to tailor treatment for diverse patient populations
- Learn about the psychosocial impacts of AA on patient lives and the importance of cultural sensitivity in clinical care
- Understand the role of multidisciplinary care in addressing the psychosocial challenges of AA and improving patient outcomes
of interest
are looking at
saved
next event
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.